Is Coriell Institute For Medical Research Inc Legit?

Coriell Institute For Medical Research Inc demonstrates a generally stable financial position with consistent revenue generation over the past decade, averaging around $18-20 million annually, with a notable increase in the most recent periods, reaching $23.4 million in 2023. The organization has consistently managed its expenses, often operating with a slight surplus or deficit, indicating careful financial stewardship. For instance, in 2023, revenue was $23,412,391 against expenses of $22,296,737, resulting in a surplus. Assets have remained robust, fluctuating between $27 million and $39 million, providing a solid financial foundation. The organization's spending efficiency appears strong, particularly given the consistent reporting of 0% for officer compensation across all available filings. This suggests that executive compensation is either not reported in this specific field or is exceptionally low, which is a positive indicator for donor confidence. While a detailed breakdown of program, administrative, and fundraising expenses is not provided in the summary data, the overall financial health, marked by consistent revenue and asset levels, suggests effective resource allocation. The absence of reported officer compensation also points to a high degree of transparency regarding leadership costs. Overall, Coriell Institute For Medical Research Inc appears to be a financially sound and well-managed organization. Its ability to maintain significant assets and generate substantial revenue, coupled with the reported 0% officer compensation, indicates a strong commitment to its mission and efficient use of resources. The recent growth in revenue and assets further solidifies its financial health and capacity to continue its medical research endeavors.